News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
624,787 Results
Type
Article (44699)
Company Profile (340)
Press Release (579738)
Multimedia
Podcasts (118)
Webinars (21)
Section
Business (168653)
Career Advice (2470)
Deals (30530)
Drug Delivery (124)
Drug Development (79273)
Employer Resources (148)
FDA (14750)
Job Trends (13102)
News (298090)
Policy (28792)
Tag
2027 BioMidwest Elite (1)
2027 Biotech Bay Standard (1)
2027 Biotech Beach Elite (1)
2027 Genetown Elite (3)
2027 Genetown Standard (1)
2027 Pharm Country Elite (1)
2027 Pharm Country Standard (3)
Academia (2707)
Academic (1)
Accelerated approval (38)
Adcomms (32)
Allergies (159)
Alliances (43149)
ALS (198)
Alzheimer's disease (1798)
Antibody-drug conjugate (ADC) (381)
Approvals (14995)
Artificial intelligence (583)
Autoimmune disease (212)
Automation (40)
Bankruptcy (327)
Best Places to Work (10687)
BIOSECURE Act (17)
Biosimilars (186)
Biotechnology (257)
Bladder cancer (178)
Brain cancer (65)
Breast cancer (684)
Cancer (5246)
Cardiovascular disease (451)
Career advice (2099)
Career pathing (41)
CAR-T (305)
CDC (52)
Cell therapy (821)
Cervical cancer (35)
Clinical research (68029)
Collaboration (1843)
Company closure (4)
Compensation (915)
Complete response letters (82)
COVID-19 (2703)
CRISPR (108)
C-suite (984)
Cystic fibrosis (150)
Data (6818)
Decentralized trials (2)
Denatured (26)
Depression (162)
Diabetes (535)
Diagnostics (6245)
Digital health (40)
Diversity (8)
Diversity, equity & inclusion (41)
Drug discovery (291)
Drug pricing (190)
Drug shortages (25)
Duchenne muscular dystrophy (278)
Earnings (65745)
Editorial (61)
Employer branding (20)
Employer resources (140)
Events (95345)
Executive appointments (1057)
FDA (17975)
Fibrodysplasia Ossificans Progressiva (7)
Friedreich's ataxia (14)
Frontotemporal dementia (29)
Funding (1533)
Gene editing (228)
Generative AI (52)
Gene therapy (696)
GLP-1 (1046)
Government (4542)
Grass and pollen (7)
Guidances (387)
Healthcare (17351)
HIV (70)
Huntington's disease (55)
IgA nephropathy (91)
Immunology and inflammation (293)
Immuno-oncology (80)
Indications (144)
Infectious disease (3009)
Inflammatory bowel disease (213)
Inflation Reduction Act (16)
Influenza (123)
Intellectual property (267)
Interviews (528)
IPO (14395)
IRA (53)
Job creations (2770)
Job search strategy (1691)
JPM (66)
Kidney cancer (20)
Labor market (68)
Layoffs (557)
Leadership (41)
Legal (6120)
Liver cancer (96)
Longevity (21)
Lung cancer (717)
Lymphoma (390)
Machine learning (49)
Management (52)
Manufacturing (828)
MASH (189)
Medical device (11528)
Medtech (11586)
Mergers & acquisitions (17212)
Metabolic disorders (1417)
mRNA (186)
Multiple sclerosis (171)
NASH (24)
Neurodegenerative disease (391)
Neuropsychiatric disorders (106)
Neuroscience (3207)
Neurotech (1)
NextGen: Class of 2026 (5993)
Non-profit (4165)
Now hiring (67)
Obesity (668)
Opinion (303)
Ovarian cancer (176)
Pain (223)
Pancreatic cancer (250)
Parkinson's disease (338)
Partnered (32)
Patents (529)
Patient recruitment (561)
Peanut (62)
People (56206)
Pharmaceutical (50)
Pharmacy benefit managers (22)
Phase 1 (21372)
Phase 2 (30025)
Phase 3 (22347)
Pipeline (6446)
Policy (308)
Postmarket research (2393)
Preclinical (9038)
Press Release (60)
Prostate cancer (270)
Psychedelics (57)
Radiopharmaceuticals (306)
Rare diseases (1013)
Real estate (4552)
Recruiting (64)
Regulatory (22862)
Reports (31)
Research institute (2355)
Resumes & cover letters (363)
Rett syndrome (33)
RNA editing (21)
RSV (78)
Schizophrenia (165)
Series A (261)
Series B (198)
Service/supplier (3)
Sickle cell disease (107)
Special edition (23)
Spinal muscular atrophy (167)
Sponsored (39)
Startups (3237)
State (2)
Stomach cancer (19)
Supply chain (101)
Tariffs (75)
The Weekly (90)
Vaccines (1022)
Venture capital (100)
Weight loss (442)
Women's health (89)
Worklife (19)
Date
Today (1)
Last 7 days (565)
Last 30 days (2770)
Last 365 days (28771)
2026 (6428)
2025 (29097)
2024 (33626)
2023 (37507)
2022 (48423)
2021 (52034)
2020 (50022)
2019 (42561)
2018 (32079)
2017 (29665)
2016 (28197)
2015 (32982)
2014 (25392)
2013 (20587)
2012 (21791)
2011 (22691)
2010 (20433)
Location
Africa (759)
Alabama (88)
Alaska (4)
Arizona (252)
Arkansas (13)
Asia (38004)
Australia (7494)
California (11100)
Canada (3335)
China (1182)
Colorado (464)
Connecticut (453)
Delaware (355)
Europe (85643)
Florida (1690)
Georgia (342)
Hawaii (3)
Idaho (59)
Illinois (851)
India (72)
Indiana (489)
Iowa (18)
Japan (457)
Kansas (119)
Kentucky (37)
Louisiana (33)
Maine (61)
Maryland (1383)
Massachusetts (8087)
Michigan (308)
Minnesota (587)
Mississippi (6)
Missouri (131)
Montana (29)
Nebraska (25)
Nevada (119)
New Hampshire (82)
New Jersey (3069)
New Mexico (26)
New York (2936)
North Carolina (1440)
North Dakota (7)
Northern California (5368)
Ohio (312)
Oklahoma (16)
Oregon (38)
Pennsylvania (2223)
Puerto Rico (24)
Rhode Island (44)
South America (1029)
South Carolina (67)
South Dakota (1)
Southern California (4459)
Tennessee (171)
Texas (1761)
United States (39550)
Utah (349)
Vermont (1)
Virginia (254)
Washington D.C. (71)
Washington State (915)
West Virginia (4)
Wisconsin (108)
Wyoming (2)
624,787 Results for "akashi therapeutics formerly known as dart therapeutics".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Aligos Therapeutics Presents Positive Data at HEP-DART 2025
December 12, 2025
·
6 min read
Press Releases
HekaBio and Alpha Tau Medical Obtain Approval in Japan for Solid Tumor Treatment Alpha DaRT
February 25, 2026
·
7 min read
Press Releases
Alpha Tau Medical Receives Japanese Marketing Approval for Alpha DaRT® in Unresectable Locally Advanced or Locally Recurrent Head and Neck Cancer
February 24, 2026
·
7 min read
Press Releases
Alpha Tau Reports New Positive Results in Two Upcoming Presentations at ASCO GI 2026 Symposium Showcasing Immune-Preservation and High Disease Control in Montreal Pancreatic Cancer Alpha DaRT® Study
January 7, 2026
·
7 min read
Press Releases
Alpha Tau Announces Presentation of Two Alpha DaRT Pancreatic Cancer Abstracts at Upcoming 2026 ASCO GI Symposium
December 5, 2025
·
5 min read
Press Releases
Enthorin Therapeutics Announces Initiation of Phase II Clinical Trial of MRM-3379 (Formerly ENT-3379) for Fragile X Syndrome by Licensing Partner Mirum Pharmaceuticals
January 12, 2026
·
2 min read
Press Releases
Precision BioSciences Announces Presentation of Clinical Data from the ELIMINATE-B Trial at HEP-DART 2025
November 20, 2025
·
6 min read
Press Releases
Alpha Tau Submits First Pre-Market Approval Module to the FDA for Alpha DaRT® for the Treatment of Recurrent Cutaneous Squamous Cell Carcinoma (cSCC)
January 5, 2026
·
5 min read
Press Releases
CRISPR Therapeutics Provides Broad Update on Zugocaptagene Geleucel (Zugo-cel; formerly CTX112™) in Autoimmune Diseases and Hematologic Malignancies
December 23, 2025
·
9 min read
Press Releases
Cypherpunk Technologies (formerly Leap Therapeutics) Reports Third Quarter 2025 Financial Results
November 13, 2025
·
16 min read
1 of 62,479
Next
